VALIDATION OF A NOVEL CYTOMEGALOVIRUS-SPECIFIC ELISPOT ASSAY TO MONITOR THE FUNCTIONALITY OF CELL-MEDIATED IMMUNITY IN HEMODIALYSIS PATIENTS

被引：0
|
作者：
Banas, B. [1 ]
Boeger, C. [1 ]
Lueckhoff, G. [2 ]
Krueger, B. [3 ]
Barabas, S. [4 ]
Starke, A. [4 ]
Schemmerer, M. [4 ]
Rascle, A. [4 ]
Koestler, J. [5 ]
Wagner, R. [4 ,5 ]
Deml, L. [4 ]
Leicht, J. [6 ]
Kraemer, B. [3 ]
机构：
[1] Univ Med Ctr Regensburg, Dept Nephrol, Regensburg, Germany
[2] Dialysis Ctr Landshut, Landshut, Germany
[3] Univ Med Ctr Mannheim, Dept Med 5, Mannheim, Germany
[4] Lophius Biosci, Regensburg, Germany
[5] Univ Regensburg, Inst Med Microbiol & Hyg, Regensburg, Germany
[6] Dialysis Ctr Schwandorf, Schwandorf, Germany
来源：
TRANSPLANT INTERNATIONAL | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
PV005
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [41] Prevention of cytomegalovirus disease in patients with impaired cell-mediated immunity - is there a need for maribavir?
    Bommer, Martin
    Michel, Detlef
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (10): : 829 - 836
  • [42] CLINICAL VALIDATION OF A STANDARDIZED ELISPOT-BASED ASSAY TO MONITOR CMV-SPECIFIC CELLULAR IMMUNITY IN KIDNEY TRANSPLANT RECIPIENTS
    Banas, Bernard
    Steubel, Dominik
    Renders, Lutz
    Chittka, Dominik
    Banas, Miriam C.
    Wekerle, Thomas
    Koch, Martina
    Witzke, Oliver
    Muehlfeld, Anja
    Sommerer, Claudia
    Habicht, Antja
    Hugo, Christian
    Huenig, Thomas
    Lindemann, Monika
    Eder, Katharina
    Schmidt, Traudel
    Rascle, Anne
    Barabas, Sascha
    Deml, Ludwig
    Wagner, Ralf
    Kraemer, Bernhard K.
    Krueger, Bernd
    TRANSPLANT INTERNATIONAL, 2019, 32 : 101 - 101
  • [43] Validation of the Suitability of Lophius Kits T-Track® CMV and T-Track® EBV to Assess the Functionality of Cell-Mediated Immunity (CMI) in Hemodialysis Patients
    Banas, B.
    Boeger, C.
    Lueckhoff, G.
    Krueger, B.
    Batzilla, J.
    Schemmerer, M.
    Koestler, J.
    Deml, L.
    Leicht, J.
    Kraemer, B. K.
    TRANSPLANTATION, 2012, 94 (10) : 1175 - 1175
  • [44] Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation
    Wagner-Drouet, Eva
    Teschner, Daniel
    Wolschke, Christine
    Schaefer-Eckart, Kerstin
    Gaertner, Johannes
    Mielke, Stephan
    Schreder, Martin
    Kobbe, Guido
    Hilgendorf, Inken
    Klein, Stefan
    Verbeek, Mareike
    Ditschkowski, Markus
    Koch, Martina
    Lindemann, Monika
    Schmidt, Traudel
    Rascle, Anne
    Barabas, Sascha
    Deml, Ludwig
    Wagner, Ralf
    Wolff, Daniel
    DIAGNOSTICS, 2021, 11 (02)
  • [45] Partial restoration of cytokine profile despite reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients during highly active antiretroviral treatment
    Alfonzo, M
    Blanc, D
    Troadec, C
    Eliaszewicz, M
    Gónzalez, G
    Scott-Algara, D
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2003, 57 (04) : 375 - 383
  • [46] Characterization of hepatitis E-specific cell-mediated immune response using IFN-γ ELISPOT assay
    Shata, M. T.
    Barrett, A.
    Shire, N. J.
    Abdelwahab, S. F.
    Sobhy, M.
    Daef, E.
    El-Kamary, S. S.
    Hashem, M.
    Engle, R. E.
    Purcell, R. H.
    Emerson, S. U.
    Strickland, G. T.
    Sherman, K. E.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2007, 328 (1-2) : 152 - 161
  • [47] Cytomegalovirus specific cell-mediated immunity status in women with preeclampsia: A case-control study
    Sherkat, Roya
    Shahshahan, Zahra
    Kalatehjari, Maryam
    Yaran, Majid
    Nasirian, Maryam
    Najafi, Somayeh
    Zangeneh, Neda
    Montazerin, Sahar
    ADVANCED BIOMEDICAL RESEARCH, 2023, 12 (01): : 10
  • [48] Monitoring of cytomegalovirus-specific immunity using the QuantiFERON-CMV assay in hematopoietic cell transplant recipients: Preliminary results
    Ribeiro, Joana
    Vaz, C. Pinho
    Campilho, F.
    Branca, R.
    Campos, A., Jr.
    Baldaque, I.
    Sousa, H.
    JOURNAL OF CLINICAL VIROLOGY, 2016, 82 : S101 - S101
  • [49] CLINICAL VALIDATION OF T-TRACK® CMV TO ASSESS THE FUNCTIONALITY OF CMV-SPECIFIC CELL-MEDIATED IMMUNITY IN KIDNEY TRANSPLANT RECIPIENTS
    Banas, B.
    Steubl, D.
    Renders, L.
    Wekerle, T.
    Koch, M.
    Witzke, O.
    Muehlfeld, A.
    Sommerer, C.
    Habicht, A.
    Hugo, C.
    Huenig, T.
    Lindemann, M.
    Barabas, S.
    Deml, L.
    Wagner, R.
    Krueger, B.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 20 - 20
  • [50] Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment
    Fernandez-Ruiz, M.
    Gimenez, E.
    Vinuesa, V.
    Ruiz-Merlo, T.
    Parra, P.
    Amat, P.
    Montejo, M.
    Paez-Vega, A.
    Cantisan, S.
    Torre-Cisneros, J.
    Fortun, J.
    Andres, A.
    San Juan, R.
    Lopez-Medrano, F.
    Navarro, D.
    Aguado, J. M.
    Gonzalez, Esther
    Polanco, Natalia
    Rodriguez, Regino
    Aranzamendi, Maitane
    Carmona, Oriana
    Escudero, Rosa
    Martin-Davila, Pilar
    Fernandez, Ana
    Aguado, Rocio
    Vidal, Elisa
    Luisa Aguera, Maria
    Rodriguez-Benot, Alberto
    Rodelo-Haad, Cristian
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (03) : 381.e1 - 381.e10
12345